Keyuan Pharmaceutical announced that Linuo Pharmaceutical, a wholly-owned subsidiary, recently received drug registration certificates for engglicin metformin extended-release tablets and engagliptin metformin sustained-release tablets issued by the State Drug Administration. The approval numbers are Sinopharm Standard H20265843 and Sinopharm Standard H20265844, respectively.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.